Copenhagen Phase IV Unit, Denmark
The Copenhagen Phase IV Unit (Phase4Cph)
By applying state of the art research methodology, Phase4Cph creates insight in evidence-based use of medications: drug utilization, safety, effectiveness and health economics.
We have a profound insight in the Danish health registries, allowing us unique opportunities to investigate drug-exposure outcome relations. We have experience with studies on marketed drugs, both in broad populations and in specific subgroups. Furthermore, we have access to prospective cohorts, with a wide range of clinical measurements.
We engage in
Public-private partnerships
Health authority-initiated studies
Post-authorization safety (PASS) and efficacy studies (PAES)
Comparative effectiveness research (CER)
Real world evidence on drug effectiveness, safety and utilization
Potential new indications for established drugs
Phase4Cph is a collaboration between Center for Clinical Research and Prevention and the Department of Clinical Pharmacology at Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.